Eli Lilly cleared a significant regulatory hurdle this week when the Food and Drug Administration approved Foundayo, its once-daily oral medication for weight loss, sending shares of the pharmaceutical giant up 4% on Wednesday. The drug, whose generic name is orforglipron, represents the company’s second FDA-approved obesity treatment and its first in pill form. The […]

The postEli Lilly’s Foundayo could upend the obesity marketappeared first onRolling Out.